Publications

15 résultats Voir en premier : les plus pertinents | les plus récents
    • Drogues, Statistiques
    • 2015
    • Rapport
    • Français, Portugais, Allemand, Anglais

    Le rapport de cette année offre un aperçu complet du problème de la drogue en Europe et des mesures prises pour y faire face. Le rapport «Tendances et évolutions» est l’élément central de la série de produits connexes qui comprend le rapport européen sur les drogues. S’appuyant sur des données nationales et européennes, il fournit une vue d’ensemble des tendances, réponses et politiques majeures, ainsi que des analyses approfondies de sujets d’actualité. Le rapport contient des analyses totalement nouvelles sur les interventions psycho-sociales, les salles de consommation de drogue, la consommation abusive de benzodiazépines et les itinéraires du trafic d’héroïne.

    Le dossier d’information multimédia intégré qui constitue aujourd’hui le rapport européen sur les drogues diffère, toutefois, du rapport annuel de l’EMCDDA sur la situation en matière de drogue publié en 1996. Pour l’EMCDDA, il y a vingt ans, établir, dans les 15 États membres de l’UE, des systèmes de surveillance harmonisés doit avoir représenté un défi de taille. Il est, dès lors, impressionnant de constater que les modalités d’observation nouvellement établies en 1995 ont évolué pour constituer, à présent, un système européen couvrant trente pays et reconnu à l’échelle mondiale.

    L’analyse de cette année souligne l’importance des facteurs mondiaux sur l’offre de drogue et les discussions politiques

    • Date de parution:
    • Editeur: Office des publications de l'Union européenne
    • Maladies, Statistiques
    • 2015
    • Rapport
    • Anglais

    [Surveillance et suivi de la tuberculose en Europe 2015]
    The seventh report launched jointly by ECDC and the WHO Regional Office for Europe indicates that, despite notable progress in the past decade, tuberculosis (TB) is still a public health concern in many countries across Europe.
    In 2013, 64 844 cases of TB were reported in 30 EU/EEA countries, which was 6% less than in 2012, reflecting a decrease in 19 countries. The EU/EEA notification rate was 12.7 per 100 000 population, continuing a long-term decreasing trend.
    The latest figures on tuberculosis are available via ECDC’s Surveillance Atlas of Infectious Diseases, a web-based tool offering access to European infectious disease surveillance data which is searchable by disease, region and period.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC) Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Statistiques, Maladies, Santé sexuelle
    • 2015
    • Rapport
    • Anglais

    This summary includes data on newly diagnosed cases of hepatitis C reported to ECDC by EU/EEA countries for 2013. Countries were requested to follow the 2012 EU hepatitis C case definition for reporting at the European level, but data were still accepted if other case definitions were used.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
    • Médicaments, Statistiques
    • 2015
    • Rapport
    • Anglais

    [Résumé des dernières données sur la consommation d'antibiotiques dans l'européenne]
    Data on the occurrence and spread of antimicrobial resistance in the European countries.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
    • Système de santé, Statistiques
    • 2015
    • Rapport
    • Français, Anglais

    Le Panorama de la santé 2015 présente des comparaisons internationales de l’état de santé des populations et des performances des systèmes de santé dans les pays de l'OCDE, les pays candidats et certains grands pays émergents. L’édition 2015 contient deux nouveautés : une série d’indicateurs relatifs à la santé et aux systèmes de santé dans les pays de l'OCDE présentés sous forme de tableaux de bord au chapitre 1, et un chapitre spécial consacré à l’évolution récente des dépenses pharmaceutiques.

    Version française Panorama de la santé 2015 consultable en ligne sur le site de l'OCDE

    Version anglaise Health at a Glance 2015 consultable en ligne sur le site de l'OCDE

    • Date de parution:
    • Editeur: Organisation de Coopération et de Développement Economiques (OCDE)
    • Santé mentale, Politique internationale, Statistiques
    • 2015
    • Rapport
    • Anglais

    [Atlas de la santé mentale 2014]

    WHO’s Mental Health Atlas series has already established itself as the single most comprehensive and most widely used source of global information on mental health situation. This new edition of Mental Health Atlas, carried out in 2014, assumes new importance as a repository of mental health information in WHO Member States because it is providing much of the baseline data against which progress towards the objectives and targets of the Comprehensive Mental Health Action Plan 2013-2020 is to be measured. The Action Plan contains four objectives:

    1. To strengthen effective leadership and governance for mental health
    2. To provide comprehensive, integrated and responsive mental health and social care services in community based settings
    3. To implement strategies for promotion and prevention in mental health
    4. To strengthen information systems, evidence and research for mental health

    Global targets have been established for each of these objectives to measure collective action and achievement by Member States towards the overall goal of the Action Plan. Atlas is the mechanism through which indicators in relation to agreed global targets, as well as a set of other core mental health indicators, are being collected. In collecting this information, the mental health Atlas 2014 questionnaire covers critical areas of mental health system development, including governance and financing, human resources, service availability and delivery, promotion and prevention, and surveillance.

    Subsequent to this baseline data collection in 2014, a Mental Health Atlas survey will be sent to country focal points periodically, so that progress towards meeting the targets of the Action Plan can be measured over time.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Statistiques, Drogues
    • 2015
    • Rapport
    • Anglais

    [Rapport mondial sur les drogues 2015]
    The World Drug Report presents a comprehensive annual overview of the latest developments in the world's illicit drug markets by focusing on the production, trafficking and consumption of the main types of illicit drugs, along with the related health consequences of those drugs. Chapter 1 of the World Drug Report 2015 not only provides a global overview of the supply of and demand for opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances, as well as their impact on health, but also provides a review of the scientific evidence on approaches to preventing drug use and addresses general principles for effective responses to treatment for drug use. Chapter 2 examines how alternative development, within the broader context of the development agenda, is aimed at breaking the vicious cycle of illicit crop cultivation by providing farmers with alternative livelihoods.

    • Date de parution:
    • Editeur: United Nations
    • Médicaments, Statistiques
    • 2015
    • Rapport
    • Anglais

    [Surveillance de l'antibiorésistance en Europe]
    Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).
    This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci. For 2014, data were reported by 29 countries and the report also presents trend analyses for the period 2011–2014.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
    • Drogues, Statistiques
    • 2015
    • Article
    • Anglais

    BACKGROUND:
    To determine the existence of a social gradient in fatal overdose cases related to non-prescribed opioids and cocaine use, recorded in Luxembourg between 1994 and 2011.
    METHODS:
    Overdose cases were individually matched with four controls in a nested case-control study design, according to sex, year of birth, drug administration route and duration of drug use. The study sample, composed of 272 cases and 1,056 controls, was stratified according to a Social Inequality Accumulation Score (SIAS), based on educational attainment, employment, income, financial situation of subjects and the professional status of their father or legal guardian. Least squares linear regression analysis on overdose mortality rates and ridit scores were applied to determine the Relative Index of Inequality (RII) of the study sample.
    RESULTS:
    A negative linear relationship between the overdose mortality rate and the relative socioeconomic position was observed. We found a difference in mortality of 29.22 overdose deaths per 100 drug users in the lowest socioeconomic group compared to the most advantaged group. In terms of the Relative Inequality Index, the overdose mortality rate of opioid and cocaine users with lowest socioeconomic profiles was 9.88 times as high as that of their peers from the highest socioeconomic group (95% CI 6.49-13.26).
    CONCLUSIONS:
    Our findings suggest the existence of a marked social gradient in opioids and cocaine related overdose fatalities. Harm reduction services should integrate socially supportive offers, not only because of their general aim of social (re)integration but crucially in order to meet their most important objective, that is to reduce drug-related mortality.

    Souce: Pubmed

    • Date de parution:
    • Editeur: Plos One
    • Santé sexuelle, Maladies, Statistiques
    • 2015
    • Rapport
    • Anglais

    This summary includes data on newly diagnosed cases of hepatitis B reported to ECDC by EU/EEA countries for 2013. Countries were requested to follow the EU 2012 case definition for hepatitis B reporting at the European level, but other case definitions were also accepted.

    • Date de parution:
    • Editeur: European Centre for Disease prevention and Control (ECDC)
  • Dernière modification le 12-10-2015